Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Impact of adoption of ASU No. 2016-13	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Impact of adoption of ASU No. 2016-13	Accumulated Other Comprehensive (Loss) Income, net of tax
Balance, beginning of period (in shares) at Dec. 31, 2022			2,583,619
Balance, beginning of period at Dec. 31, 2022	$ 97,705	$ (1,149)	$ 26	$ 28,004	$ 70,792	$ (1,149)	$ (1,117)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,439				7,439
Other comprehensive income (loss), net of tax (benefit)	129						129
Share-based compensation	450			450
Restricted stock awards issued (in shares)			8,850
Cash dividends on common stock	$ (1,913)				(1,913)
Common stock repurchased (in shares)	(58,035)		(58,035)
Common stock repurchased	$ (2,137)		$ (1)	(594)	(1,542)
Common stock surrendered (in shares)			(6,799)
Common stock surrendered	(265)			(265)
Restricted shares forfeited (in shares)			(755)
Common stock options exercised (in shares)			22,547
Common stock options exercised	$ 395			395
Balance, end of period (in shares) at Dec. 31, 2023	2,549,427		2,549,427
Balance, end of period at Dec. 31, 2023	$ 100,654		$ 25	27,990	73,627		(988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,640				4,640
Other comprehensive income (loss), net of tax (benefit)	(56)						(56)
Share-based compensation	390			390
Restricted stock awards issued (in shares)			8,048
Cash dividends on common stock	$ (1,948)				(1,948)
Common stock repurchased (in shares)	(1,626)		(1,626)
Common stock repurchased	$ (65)			(18)	(47)
Common stock surrendered (in shares)			(5,053)
Common stock surrendered	(218)			(218)
Common stock options exercised (in shares)			14,111
Common stock options exercised	$ 269			269
Balance, end of period (in shares) at Dec. 31, 2024	2,564,907		2,564,907
Balance, end of period at Dec. 31, 2024	$ 103,666		$ 25	$ 28,413	$ 76,272		$ (1,044)